ACADIA Pharmaceuticals - 48 Year Dividend History | ACAD

Historical dividend payout and yield for ACADIA Pharmaceuticals (ACAD) since 1971. The current TTM dividend payout for ACADIA Pharmaceuticals (ACAD) as of April 23, 2019 is $0.00. The current dividend yield for ACADIA Pharmaceuticals as of April 23, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.416B $0.224B
Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.629B 12.24
Gilead Sciences (GILD) United States $78.878B 10.04
Bio-Techne Corp (TECH) United States $7.219B 48.64